Aptevo Therapeutics Inc (APVO) earnings · rev $3.1M
These earnings events as JSON? API free 100/dayAptevo Therapeutics Inc (APVO) is a biotechnology company listed on US.
This APVO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported APVO revenue for 2022-12-31 was $3.1M. Net income was $8.0M. APVO currently screens at market cap $9.9M.
When the next APVO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for APVO. We will not invent a beat or miss.
Not investment advice. Full APVO research stays on the stock page; the tape stays on the quote page.
APVO earnings FAQ
What are APVO's latest revenue and net income?
Latest cached Aptevo Therapeutics Inc (APVO) revenue for Dec 31, 2022 was $3.1M. Net income was $8.0M. Statements: https://lician.com/financials/apvo
What is APVO's latest diluted EPS?
Latest cached Aptevo Therapeutics Inc (APVO) diluted EPS for Dec 31, 2022 was $1.57.
What period does the latest APVO earnings print cover?
The latest cached Aptevo Therapeutics Inc (APVO) earnings print covers Dec 31, 2022.
Where are APVO earnings listed?
Cached earnings facts for Aptevo Therapeutics Inc (APVO) are listed at https://lician.com/earnings/apvo. Statements: https://lician.com/financials/apvo
Not investment advice.